SynthesisNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2026
Neuromodulation of the central nervous system for facial pain.
Synthesis in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic craniofacial pain can lead to significant morbidity and reduced quality-of-life. Refractory pain subsequently leads to maladaptive changes within the central nervous system (CNS). It is logical to consider modulation of implicated neural networks to mitigate or reverse these changes in order to alleviate suffering. In this report, we reviewed the current literature in neuromodulation of CNS in facial pain treatment. We conducted PRISMA-compliant systematic review using MEDLINE and EMBASE databases. We included studies applying stimulation to the CNS to treat facial pain. Demographic data, design, duration, participants, clinical details, outcomes, adverse effects were extracted. Out of 1005 unique publications, 57 were included for analysis. Main techniques included were transcranial direct current stimulation (tDCS), repetitive transcranial magnetic stimulation (rTMS), motor cortex stimulation (MCS), deep brain stimulation (DBS), and spinal cord stimulation (SCS). For tDCS, rTMS, and MCS, the main stimulation target was primary motor cortex; while several different DBS targets (e.g., thalamic nuclei, anterior cingulate cortex, periaqueductal grey matter) were studied. While most studies showed improvement in Numeric Rating Scale for pain, values range widely from 11.1% in one MCS study to 90% in one rTMS study, with majority within 20-60%. There is heterogeneity across research designs, including patient selection, outcome measures, and follow-up. Standardized reporting framework is required to allow direct comparison between different modalities within subgroups of facial pain patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.